Mahaisavariya, Chantas
Vanitcharoenkul, Ekasame
Kitcharanant, Nitchanant
Chotiyarnwong, Pojchong
Unnanuntana, Aasis
Article History
Received: 21 September 2022
Accepted: 27 January 2023
First Online: 3 February 2023
Declarations
:
: The protocol for the first phase and second phase was approved by the Siriraj Institutional Review Board of the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (COA no. Si 180/2021) and for the second phase, patients-informed consent forms used in the cross-sectional component were approved by the Siriraj Institutional Review Board of the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (COA no. Si 180/2021). The research was registered with the Thai Clinical Trials Registry (TCTR number: 20210824002). The study was conducted in accordance with the Declaration of Helsinki. Each patient (or a relative/caregiver) provided informed consent in writing or by telephone to participate in this second study phase.
: Not applicable.
: The authors declare no competing interests.